#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Human papilloma virus immunisation Neuronal ceroid lipofuscinosis Congenital generalised lipodystrophy Hypersensitivity pneumonitis Loss of consciousness Desmoplastic small round cell tumour Basal cell naevus syndrome Juvenile idiopathic arthritis Hypocalcaemia Autoimmune demyelinating disease Encephalopathy neonatal X-linked lymphoproliferative syndrome Arteriovenous malformation Hereditary neuropathic amyloidosis Hairy cell leukaemia recurrent More trials…

    Learn about Rare Diseases

    Glycogen storage disease type I – Life with Disease Congenital nephrogenic diabetes insipidus – Diagnostics Paraneoplastic neurological syndrome – Diagnostics Vascular malformation – Life with Disease Pulmonary fibrosis – Life with Disease Familial amyotrophic lateral sclerosis – Basic Information Haemophilia B without inhibitors – Trials in Disease Andersen-Tawil syndrome – Basic Information Retinoblastoma – Basic Information Idiopathic inflammatory myopathy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ribociclib Mecasermin Rinfabate Prasugrel Zilovertamab Vedotin Atacicept AP31969 SULFATE Highly Refined Fish Oil Ranibizumab 64CU-PSMA I&T Infliximab Acemetacin Estradiol Valerate Sodium Chloride Ph. Eur. Avacincaptad Pegol Jab-21822 Rbd1016 Human Normal Immunoglobulin Sodium S-Lactate Solution Methylone Paclitaxel Obaluronate More therapies…

    Learn about Your Condition

    Chronic granulomatous disease Morning sickness Vestibular disorder Pulmonary vascular disorder Hyperparathyroidism primary Mitochondrial DNA depletion Primary hyperthyroidism Bipolar disorder Cardiomyopathy Craniopharyngioma Pulmonary venous thrombosis Herpes simplex Mucous membrane pemphigoid Aneurysm ruptured Osteonecrosis of jaw More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Pomalidomide for HIV Control in Patients on ART and During Treatment Interruption

    Recruiting

    1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Pomalidomide
    Denmark Spain

  • Study on Ibuprofen vs. Conventional Treatment for Patients with Acute Myocarditis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myocarditis
    Investigated Drugs:
    • Ibuprofen
    Spain

  • Study on Milrinone for Preventing Delayed Brain Ischemia in Patients with Severe Subarachnoid Hemorrhage

    Recruiting

    3 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • Milrinone
    • Glucose Monohydrate
    France

  • Study on the Safety and Effects of Pegunigalsidase Alfa for Children and Adolescents with Fabry Disease

    Recruiting

    4 1 1
    Investigated Drugs:
    • Pegunigalsidase Alfa
    Austria France Norway Spain

  • Study of Pioglitazone and Avelumab Combined with Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients with Complete Cytogenetic Response

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Pioglitazone
    • Avelumab
    France

  • Study on the Effectiveness of Hormonal Treatment with Estradiol Hemihydrate and Testosterone in Adolescents with Gender Dysphoria

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Testosterone
    • Estradiol Hemihydrate
    France
Previous Page
1 … 370 371 372 373 374 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!